XORTX Therapeutics Inc 20-F for FY2022
XORTX Therapeutics Inc. (XRTX)
20-F
2023-04-28
For: 2022-12-31
View Original
Added on
April 05, 2026
About this 20-F
XORTX Therapeutics Inc filed this 20-F on April 28, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- 9.49M CAD
- compared with a net loss of 1.65M CAD a year earlier
- Diluted EPS
- -0.71 CAD
- compared with -0.17 CAD a year earlier